{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:59:21Z","timestamp":1793984361211,"version":"4.8.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T00:00:00Z","timestamp":1622160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.eclinm.2021.100966","type":"journal-article","created":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T03:12:28Z","timestamp":1624763548000},"page":"100966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement"],"prefix":"10.1016","volume":"37","author":[{"given":"John A.","family":"Belperio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-2609","authenticated-orcid":false,"given":"Faisal","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Abtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-9191","authenticated-orcid":false,"given":"Edmund","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Joseph P.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.100966_bib0001","first-page":"229","article-title":"Extrapulmonary sarcoidosis","volume":"13","author":"Lynch","year":"1998","journal-title":"Semin Respir Infect"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100966_bib0002","first-page":"204","article-title":"Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7\u20138","key":"10.1016\/j.eclinm.2021.100966_bib0003","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100966_bib0004","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00119-2019","article-title":"The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation","volume":"55","author":"Huppertz","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100966_bib0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0006","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI93537","article-title":"Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction","volume":"127","author":"Weigt","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100966_bib0007","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.eclinm.2021.100966_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-4-10","article-title":"Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis","volume":"4","author":"Palchevskiy","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"9","key":"10.1016\/j.eclinm.2021.100966_bib0009","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007582","article-title":"Inflammasome formation in granulomas in cardiac sarcoidosis","volume":"12","author":"Kron","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100966_bib0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0011","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0040-1712535","article-title":"Cardiac Sarcoidosis","volume":"41","author":"Birnie","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100966_bib0012","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.eclinm.2021.100966_bib0013","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.eclinm.2021.100966_bib0014","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.hlc.2019.07.007","article-title":"The utility of whole body (18)F-FDG PET-CT in diagnosing isolated cardiac sarcoidosis: the western Australian cardiac sarcoid study","volume":"29","author":"Giudicatti","year":"2020","journal-title":"Heart Lung Circ"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.eclinm.2021.100966_bib0017","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1177\/1925362118797744","article-title":"Cardiac involvement in sarcoidosis deaths in Wayne County, Michigan: a 20-year retrospective study","volume":"8","author":"Webb","year":"2018","journal-title":"Acad Forensic Pathol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0018","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"19","key":"10.1016\/j.eclinm.2021.100966_bib0019","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American heart association, the American college of cardiology, and the European society of cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0021","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00259-015-3181-8","article-title":"Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis","volume":"43","author":"Ohira","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0022","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008975","article-title":"Diagnostic accuracy of advanced imaging in cardiac sarcoidosis","volume":"12","author":"Divakaran","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.111.090662","article-title":"The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience","volume":"53","author":"Youssef","year":"2012","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0024","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jjcc.2012.08.002","article-title":"Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis","volume":"60","author":"Shafee","year":"2012","journal-title":"J Cardiol"},{"key":"10.1016\/j.eclinm.2021.100966_bib0025","article-title":"Cardiac magnetic resonance imaging for diagnosis of cardiac sarcoidosis: a meta-analysis","volume":"2018","author":"Zhang","year":"2018","journal-title":"Can Respir J"},{"issue":"9","key":"10.1016\/j.eclinm.2021.100966_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.eclinm.2021.100966_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2020.08.007","article-title":"Utility of cardiac magnetic resonance imaging versus cardiac positron emission tomography for risk stratification for ventricular arrhythmias in patients with cardiac sarcoidosis","author":"Gowani","year":"2020","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa146","article-title":"A case series on inflammatory cardiomyopathy and suspected cardiac sarcoidosis: role of cardiac PET in management","volume":"4","author":"Kennel","year":"2020","journal-title":"Eur Heart J Case Rep"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0029","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1378\/chest.07-2784","article-title":"Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing","volume":"133","author":"Mehta","year":"2008","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","article-title":"Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation","volume":"4","author":"Mehta","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"9","key":"10.1016\/j.eclinm.2021.100966_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0032","first-page":"133","article-title":"Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block","volume":"20","author":"Kato","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100966_bib0033","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-1275","article-title":"Effect of corticosteroid therapy on long-term clinical outcome and left ventricular function in patients with cardiac sarcoidosis","volume":"79","author":"Nagai","year":"2015","journal-title":"Circ J"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0034","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.amjcard.2015.12.033","article-title":"Effect of discontinuation of prednisolone therapy on risk of cardiac mortality associated with worsening left ventricular dysfunction in cardiac sarcoidosis","volume":"117","author":"Nagai","year":"2016","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.eclinm.2021.100966_bib0035","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0036","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.eclinm.2021.100966_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jjcc.2013.07.007","article-title":"Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis","author":"Yodogawa","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.eclinm.2021.100966_bib0038","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.eclinm.2021.100966_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2020.08.001","article-title":"Tumor necrosis factor-alpha inhibitor use for treatment of refractory cardiac sarcoidosis in a patient with left ventricular assist device: adalimumab use in refractory sarcoidosis in a patient with left ventricular assist device","author":"Krishnan","year":"2020","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.eclinm.2021.100966_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2020.09.130","article-title":"Clinical and imaging response to tumor necrosis factor alpha inhibitors in treatment of cardiac sarcoidosis: a multicenter experience","author":"Gilotra","year":"2020","journal-title":"J Card Fail"},{"issue":"21","key":"10.1016\/j.eclinm.2021.100966_bib0041","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0042","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","article-title":"Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias","volume":"7","author":"Crawford","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100966_bib0043","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.healun.2007.05.006","article-title":"Outcome of heart transplantation in patients with sarcoid cardiomyopathy","volume":"26","author":"Zaidi","year":"2007","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0044","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0037-1604165","article-title":"Neurosarcoidosis","volume":"38","author":"Culver","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAO.0000000000000501","article-title":"Cranial base manifestations of neurosarcoidosis: a review of 305 patients","volume":"36","author":"Carlson","year":"2015","journal-title":"Otol Neurotol"},{"issue":"10","key":"10.1016\/j.eclinm.2021.100966_bib0046","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","article-title":"Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients","volume":"105","author":"Langrand","year":"2012","journal-title":"QJM"},{"issue":"14","key":"10.1016\/j.eclinm.2021.100966_bib0047","doi-asserted-by":"crossref","first-page":"e3277","DOI":"10.1097\/MD.0000000000003277","article-title":"Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study","volume":"95","author":"Leonhard","year":"2016","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0048","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","article-title":"Long-term outcomes of refractory neurosarcoidosis treated with infliximab","volume":"264","author":"Cohen Aubart","year":"2017","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0049","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0733-8619(03)00054-9","article-title":"Neurologic manifestations of sarcoidosis","volume":"20","author":"Gullapalli","year":"2002","journal-title":"Neurol Clin"},{"issue":"12","key":"10.1016\/j.eclinm.2021.100966_bib0050","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group","volume":"75","author":"Stern","year":"2018","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0051","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","article-title":"Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study","volume":"89","author":"Cohen-Aubart","year":"2010","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0052","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s00415-016-8092-5","article-title":"Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients","volume":"263","author":"Durel","year":"2016","journal-title":"J Neurol"},{"issue":"24","key":"10.1016\/j.eclinm.2021.100966_bib0053","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"Bitoun","year":"2016","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.eclinm.2021.100966_bib0054","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jamaneurol.2017.2492","article-title":"Association of prognostic factors and immunosuppressive treatment with long-term outcomes in neurosarcoidosis","volume":"74","author":"Joubert","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.eclinm.2021.100966_bib0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.03.011","article-title":"Sarcoidosis-associated small fiber neuropathy in a large cohort: clinical aspects and response to IVIG and anti-TNF alpha treatment","volume":"126","author":"Tavee","year":"2017","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0056","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1038\/s41598-018-27554-3","article-title":"Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan","volume":"8","author":"Hattori","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0057","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.rmed.2014.12.012","article-title":"Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan","volume":"109","author":"Sawahata","year":"2015","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0058","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0040-1710536","article-title":"Ocular sarcoidosis","volume":"41","author":"Seve","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0059","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0037-1602382","article-title":"Ocular involvement in sarcoidosis","volume":"38","author":"Groen","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41433-018-0223-z","article-title":"Noninfectious uveitis in the Asia-Pacific region","volume":"33","author":"Hsu","year":"2019","journal-title":"Eye"},{"issue":"11","key":"10.1016\/j.eclinm.2021.100966_bib0061","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00417-019-04415-x","article-title":"Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis","volume":"257","author":"Coulon","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.eclinm.2021.100966_bib0062","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ajo.2018.09.013","article-title":"Sarcoidosis-related uveitis: clinical presentation, disease course, and rates of systemic disease progression after uveitis diagnosis","volume":"198","author":"Ma","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0063","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2017.07.006","article-title":"International ocular sarcoidosis working g. distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients","volume":"125","author":"Acharya","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0064","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13023-017-0638-9","article-title":"Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center","volume":"12","author":"Ness","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"10.1016\/j.eclinm.2021.100966_bib0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/09273948.2018.1497665","article-title":"New insights on ocular sarcoidosis: an optical coherence tomography angiography study","volume":"27","author":"Cerquaglia","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.eclinm.2021.100966_bib0066","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.eclinm.2021.100966_bib0067","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajo.2010.12.011","article-title":"Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases","volume":"151","author":"Demirci","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0068","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0069","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ajo.2007.07.019","article-title":"Diverse clinical presentations of orbital sarcoid","volume":"144","author":"Mavrikakis","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.eclinm.2021.100966_bib0070","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2011-300129","article-title":"Minor salivary gland biopsy in diagnosing ocular sarcoidosis","volume":"95","author":"Blaise","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0071","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archopht.1993.01090050076033","article-title":"Transbronchial lung biopsy in the diagnosis of suspected ocular sarcoidosis","volume":"111","author":"Ohara","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"10.1016\/j.eclinm.2021.100966_bib0072","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1136\/bjophthalmol-2018-313133","article-title":"(18)F-fluorodeoxyglucose positron emission tomography is useful for the diagnosis of intraocular sarcoidosis in patients with a normal CT scan","volume":"103","author":"Chauvelot","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0073","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4187\/respcare.02101","article-title":"Efficacy and safety of conventional transbronchial needle aspiration in sarcoidosis: a systematic review and meta-analysis","volume":"58","author":"Agarwal","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.eclinm.2021.100966_bib0074","article-title":"Recommendations for the management of ocular sarcoidosis from the international workshop on ocular sarcoidosis","author":"Takase","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.eclinm.2021.100966_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ophtha.2018.08.021","article-title":"Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the periocular vs. intravitreal corticosteroids for uveitic macular edema (POINT) trial","volume":"126","author":"Thorne","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.eclinm.2021.100966_bib0076","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ophtha.2015.01.003","article-title":"Sarcoidosis in the national veteran population: association of ocular inflammation and mortality","volume":"122","author":"Birnbaum","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.eclinm.2021.100966_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08820538.2016.1206576","article-title":"Clinical manifestations, complications and treatment of ocular sarcoidosis: correlation between visual efficiency and macular edema as seen on optical coherence tomography","author":"Paovic","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"11","key":"10.1016\/j.eclinm.2021.100966_bib0078","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/S0161-6420(96)30417-X","article-title":"Prognosticators for visual outcome in sarcoid uveitis","volume":"103","author":"Dana","year":"1996","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.eclinm.2021.100966_bib0079","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/09273948.2014.920034","article-title":"Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography","volume":"22","author":"Gungor","year":"2014","journal-title":"Ocul Immunol Inflamm"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021002467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:06:33Z","timestamp":1762887993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021002467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":79,"alternative-id":["S2589537021002467"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100966","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrapulmonary sarcoidosis with a focus on cardiac, nervous system, and ocular involvement","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.100966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100966"}}